Home/Sisu Pharma/Dennis J. Thiele, Ph.D.
DJ

Dennis J. Thiele, Ph.D.

Founder, Chief Scientific Officer, Member Scientific Advisory Board

Sisu Pharma

Sisu Pharma Pipeline

DrugIndicationPhase
HSF1 Degrader ProgramOncology (Therapy-resistant cancers)Pre-clinical
HSF1 Activator ProgramNeurodegenerative DiseasesPre-clinical
HSF1 Modulator ProgramInfectious DiseasesPre-clinical